Fewer cetuximab-related skin-toxicities in colorectal cancer patients treated with encorafenib: a Yin and Yang effect of ERK paradoxical activation

Ann Oncol. 2022 Sep;33(9):981-982. doi: 10.1016/j.annonc.2022.06.002. Epub 2022 Jun 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Carbamates*
  • Cetuximab / adverse effects
  • Colorectal Neoplasms* / drug therapy
  • Humans
  • Proto-Oncogene Proteins B-raf
  • Sulfonamides

Substances

  • Carbamates
  • Sulfonamides
  • encorafenib
  • Proto-Oncogene Proteins B-raf
  • Cetuximab